Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions

Author:

Zhao Jing1,Li Hang2,Kung David3,Fisher Marc4,Shen Ying5,Liu Renyu6ORCID

Affiliation:

1. Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China (J.Z.).

2. Department of Cerebrovascular Disease, Henan Provincial People’s Hospital, Zhengzhou, China (H.L.).

3. Department of Neurosurgery and Interventional Neuroradiology (D.K.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

4. Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.).

5. Department of Traditional Chinese Medicine, Xuanwu Hospital Capital Medical University, Beijing, China (Y.S.).

6. Department of Anesthesiology and Critical Care (R.L.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

Abstract

Background and Purpose: When the coronavirus disease 2019 (COVID-19) outbreak became paramount, medical care for other devastating diseases was negatively impacted. In this study, we investigated the impact of the COVID-19 outbreak on stroke care across China. Methods: Data from the Big Data Observatory Platform for Stroke of China consisting of 280 hospitals across China demonstrated a significant drop in the number of cases of thrombolysis and thrombectomy. We designed a survey to investigate the major changes during the COVID-19 outbreak and potential causes of these changes. The survey was distributed to the leaders of stroke centers in these 280 hospitals. Results: From the data of Big Data Observatory Platform for Stroke of China, the total number of thrombolysis and thrombectomy cases dropped 26.7% ( P <0.0001) and 25.3% ( P <0.0001), respectively, in February 2020 as compared with February 2019. We retrieved 227 valid complete datasets from the 280 stroke centers. Nearly 50% of these hospitals were designated hospitals for COVID-19. The capacity for stroke care was reduced in the majority of the hospitals. Most of the stroke centers stopped or reduced their efforts in stroke education for the public. Hospital admissions related to stroke dropped ≈40%; thrombolysis and thrombectomy cases dropped ≈25%, which is similar to the results from the Big Data Observatory Platform for Stroke of China as compared with the same period in 2019. Many factors contributed to the reduced admissions and prehospital delays; lack of stroke knowledge and proper transportation were significant limiting factors. Patients not coming to the hospital for fear of virus infection was also a likely key factor. Conclusions: The COVID-19 outbreak impacted stroke care significantly in China, including prehospital and in-hospital care, resulting in a significant drop in admissions, thrombolysis, and thrombectomy. Although many factors contributed, patients not coming to the hospital was probably the major limiting factor. Recommendations based on the data are provided.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference12 articles.

1. Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak

2. Temporary emergency guidance to US stroke centers during the COVID-19 pandemic.;Lyde P;Stroke,2020

3. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China.;Mao L;JAMA Neurol,2020

4. Significant stroke knowledge deficiencies in community physician improved with stroke 120.;Liu X;J Stroke Cerebrovasc Dis,2019

5. Stroke 112

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3